Glaxosmithkline Pharmaceuticals informs about analyst meet

11 Feb 2025 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that an group analyst meeting is scheduled on 14th February 2025 via Digital.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2848.65 44.60 (1.59%)
28-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.80
Dr. Reddys Lab 1199.70
Cipla 1554.40
Lupin 2107.70
Zydus Lifesciences 885.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...